Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Pneumonectomy | Research

Value of preoperative evaluation of FEV1 in patients with destroyed lung undergoing pneumonectomy - a 20-year real-world study

Authors: Wenbo Li, Jing Zhao, Changfan Gong, Ran Zhou, Dongjie Yan, Hongyun Ruan, Fangchao Liu

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Clinical guidelines recommend a preoperative forced expiratory volume in one second (FEV1) of > 2 L as an indication for left or right pneumonectomy. This study compares the safety and long-term prognosis of pneumonectomy for destroyed lung (DL) patients with FEV1 ≤ 2 L or > 2 L.

Methods

A total of 123 DL patients who underwent pneumonectomy between November 2002 and February 2023 at the Department of Thoracic Surgery, Beijing Chest Hospital were included. Patients were sorted into two groups: the FEV1 > 2 L group (n = 30) or the FEV1 ≤ 2 L group (n = 96). Clinical characteristics and rates of mortality, complications within 30 days after surgery, long-term mortality, occurrence of residual lung infection/tuberculosis (TB), bronchopleural fistula/empyema, readmission by last follow-up visit, and modified Medical Research Council (mMRC) dyspnea scores were compared between groups.

Results

A total of 96.7% (119/123) of patients were successfully discharged, with 75.6% (93/123) in the FEV1 ≤ 2 L group. As compared to the FEV1 > 2 L group, the FEV1 ≤ 2 L group exhibited significantly lower proportions of males, patients with smoking histories, patients with lung cavities as revealed by chest imaging findings, and patients with lower forced vital capacity as a percentage of predicted values (FVC%pred) (P values of 0.001, 0.027, and 0.023, 0.003, respectively). No significant intergroup differences were observed in rates of mortality within 30 days after surgery, incidence of postoperative complications, long-term mortality, occurrence of residual lung infection/TB, bronchopleural fistula/empyema, mMRC ≥ 1 at the last follow-up visit, and postoperative readmission (P > 0.05).

Conclusions

As most DL patients planning to undergo left/right pneumonectomy have a preoperative FEV1 ≤ 2 L, the procedure is generally safe with favourable short- and long-term prognoses for these patients. Consequently, the results of this study suggest that DL patient preoperative FEV1 > 2 L should not be utilised as an exclusion criterion for pneumonectomy.
Literature
1.
go back to reference Rhee CK, Yoo KH, Lee JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17(1):67–75.CrossRefPubMed Rhee CK, Yoo KH, Lee JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17(1):67–75.CrossRefPubMed
2.
go back to reference Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2011;15(2):246–50, i. Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2011;15(2):246–50, i.
3.
go back to reference Kim SJ, Lee J, Park YS, et al. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30(6):737–42. Kim SJ, Lee J, Park YS, et al. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30(6):737–42.
4.
go back to reference Fawibe AE, Salami AK, Oluboyo PO, Desalu OO, Odeigha LO. Profile and outcome of unilateral tuberculous lung destruction in Ilorin, Nigeria. West Afr J Med. 2011;30(2):130–5. Fawibe AE, Salami AK, Oluboyo PO, Desalu OO, Odeigha LO. Profile and outcome of unilateral tuberculous lung destruction in Ilorin, Nigeria. West Afr J Med. 2011;30(2):130–5.
5.
go back to reference Yue B, Ye S, Liu F, et al. Bilateral lung transplantation for patients with destroyed lung and asymmetric chest deformity. Front Surg. 2021;8:680207. Yue B, Ye S, Liu F, et al. Bilateral lung transplantation for patients with destroyed lung and asymmetric chest deformity. Front Surg. 2021;8:680207.
6.
go back to reference Muñoz-Torrico M, Rendon A, Centis R, et al. Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis. J Bras Pneumol. 2016;42(5):374–85. Muñoz-Torrico M, Rendon A, Centis R, et al. Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis. J Bras Pneumol. 2016;42(5):374–85.
7.
go back to reference Kim SW, Lee SJ, Ryu YJ, et al. Prognosis and predictors of rebleeding after bronchial artery embolization in patients with active or inactive pulmonary tuberculosis. Lung. 2015;193(4):575–81. Kim SW, Lee SJ, Ryu YJ, et al. Prognosis and predictors of rebleeding after bronchial artery embolization in patients with active or inactive pulmonary tuberculosis. Lung. 2015;193(4):575–81.
8.
go back to reference Lee JK, Lee YJ, Park SS, et al. Clinical course and prognostic factors of pulmonary aspergilloma. Respirology. 2014;19(7):1066–72. Lee JK, Lee YJ, Park SS, et al. Clinical course and prognostic factors of pulmonary aspergilloma. Respirology. 2014;19(7):1066–72.
9.
go back to reference Okubo K, Ueno Y, Isobe J, Kato T. Emergent pneumonectomy for hemoptysis in a patient with previous thoracoplasty. J Cardiovasc Surg (Torino). 2004;45(5):515–7. Okubo K, Ueno Y, Isobe J, Kato T. Emergent pneumonectomy for hemoptysis in a patient with previous thoracoplasty. J Cardiovasc Surg (Torino). 2004;45(5):515–7.
10.
go back to reference Rivera C, Arame A, Pricopi C, et al. Pneumonectomy for benign disease: indications and postoperative outcomes, a nationwide study. Eur J Cardiothorac Surg. 2015;48(3):435–40. discussion 440. Rivera C, Arame A, Pricopi C, et al. Pneumonectomy for benign disease: indications and postoperative outcomes, a nationwide study. Eur J Cardiothorac Surg. 2015;48(3):435–40. discussion 440.
11.
go back to reference Lee Y, Kim HK, Lee S, Kim H, Kim J. Surgical correction of postpneumonectomy-like syndrome in a patient with a tuberculosis-destroyed lung. J Thorac Cardiovasc Surg. 2008;136(3):780–1. Lee Y, Kim HK, Lee S, Kim H, Kim J. Surgical correction of postpneumonectomy-like syndrome in a patient with a tuberculosis-destroyed lung. J Thorac Cardiovasc Surg. 2008;136(3):780–1.
12.
go back to reference Ruan H, Li Y, Wang Y, et al. Risk factors for respiratory failure after tuberculosis-destroyed lung surgery and increased dyspnea score at 1-year follow-up. J Thorac Dis. 2022;14(10):3737–47.CrossRefPubMedPubMedCentral Ruan H, Li Y, Wang Y, et al. Risk factors for respiratory failure after tuberculosis-destroyed lung surgery and increased dyspnea score at 1-year follow-up. J Thorac Dis. 2022;14(10):3737–47.CrossRefPubMedPubMedCentral
13.
14.
go back to reference Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK. Burden and clinical characteristics of high grade Tuberculosis destroyed lung: a nationwide study. J Thorac Dis. 2019;11(10):4224–33.CrossRefPubMedPubMedCentral Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK. Burden and clinical characteristics of high grade Tuberculosis destroyed lung: a nationwide study. J Thorac Dis. 2019;11(10):4224–33.CrossRefPubMedPubMedCentral
15.
go back to reference Boushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59(4):383–91. Boushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59(4):383–91.
16.
go back to reference Tashkin DP, Li N, Halpin D, et al. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD. Respir Med. 2013;107(12):1904–11. Tashkin DP, Li N, Halpin D, et al. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD. Respir Med. 2013;107(12):1904–11.
17.
go back to reference Ferguson MK, Siddique J, Karrison T. Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008;34(5):1085–9. Ferguson MK, Siddique J, Karrison T. Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008;34(5):1085–9.
18.
go back to reference Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006;81(5):1830–7. Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006;81(5):1830–7.
19.
go back to reference BTS guidelines. Guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56(2):89–108.CrossRef BTS guidelines. Guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56(2):89–108.CrossRef
20.
go back to reference Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):161S–77S. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):161S–77S.
21.
go back to reference Ruan H, Liu F, Han M, Gong C. Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung. BMC Pulm Med. 2021;21(1):273.CrossRefPubMedPubMedCentral Ruan H, Liu F, Han M, Gong C. Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung. BMC Pulm Med. 2021;21(1):273.CrossRefPubMedPubMedCentral
22.
go back to reference Park DW, Kim BG, Jeong YH, et al. Risk of short- and long-term pulmonary complications should be determined before surgery for tuberculosis-destroyed lung. J Thorac Dis. 2023;15(3):950–2.CrossRefPubMedPubMedCentral Park DW, Kim BG, Jeong YH, et al. Risk of short- and long-term pulmonary complications should be determined before surgery for tuberculosis-destroyed lung. J Thorac Dis. 2023;15(3):950–2.CrossRefPubMedPubMedCentral
23.
go back to reference Li Y, Hu X, Jiang G, Chen C. Pneumonectomy for treatment of destroyed lung: a retrospective study of 137 patients. Thorac Cardiovasc Surg. 2017;65(7):528–34.CrossRefPubMed Li Y, Hu X, Jiang G, Chen C. Pneumonectomy for treatment of destroyed lung: a retrospective study of 137 patients. Thorac Cardiovasc Surg. 2017;65(7):528–34.CrossRefPubMed
24.
go back to reference Halezeroglu S, Keles M, Uysal A, et al. Factors affecting postoperative morbidity and mortality in destroyed lung. Ann Thorac Surg. 1997;64(6):1635–8.CrossRefPubMed Halezeroglu S, Keles M, Uysal A, et al. Factors affecting postoperative morbidity and mortality in destroyed lung. Ann Thorac Surg. 1997;64(6):1635–8.CrossRefPubMed
25.
go back to reference Peng J, Zhao L, Wang Y, et al. A study of the correlation between total lung volume and the percent of low attenuation volume and PFT indicators in patients with preoperative lung cancer. Med (Baltim). 2023;102(29):e34201.CrossRef Peng J, Zhao L, Wang Y, et al. A study of the correlation between total lung volume and the percent of low attenuation volume and PFT indicators in patients with preoperative lung cancer. Med (Baltim). 2023;102(29):e34201.CrossRef
26.
go back to reference Bolliger CT, Wyser C, Roser H, Stulz P, Solèr M, Perruchoud AP. [Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications]. Pneumologie. 1996;50(5):334–41.PubMed Bolliger CT, Wyser C, Roser H, Stulz P, Solèr M, Perruchoud AP. [Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications]. Pneumologie. 1996;50(5):334–41.PubMed
27.
go back to reference Bai L, Hong Z, Gong C, Yan D, Liang Z. Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. Eur J Cardiothorac Surg. 2012;41(2):335–40.CrossRefPubMed Bai L, Hong Z, Gong C, Yan D, Liang Z. Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. Eur J Cardiothorac Surg. 2012;41(2):335–40.CrossRefPubMed
28.
go back to reference Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2433–43.CrossRefPubMedPubMedCentral Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2433–43.CrossRefPubMedPubMedCentral
29.
go back to reference Chai XQ, Ma J, Xie YH, Wang D, Chen KZ. Flurbiprofen axetil increases arterial oxygen partial pressure by decreasing intrapulmonary shunt in patients undergoing one-lung ventilation. J Anesth. 2015;29(6):881–6.CrossRefPubMed Chai XQ, Ma J, Xie YH, Wang D, Chen KZ. Flurbiprofen axetil increases arterial oxygen partial pressure by decreasing intrapulmonary shunt in patients undergoing one-lung ventilation. J Anesth. 2015;29(6):881–6.CrossRefPubMed
30.
go back to reference Torres MF, Porfirio GJ, Carvalho AP, Riera R. Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients. Cochrane Database Syst Rev. 2015;(9):CD010355. Torres MF, Porfirio GJ, Carvalho AP, Riera R. Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients. Cochrane Database Syst Rev. 2015;(9):CD010355.
31.
go back to reference Horino T, Tokunaga R, Miyamoto Y, et al. The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection. Ann Gastroenterol Surg. 2022;6(1):83–91.CrossRefPubMed Horino T, Tokunaga R, Miyamoto Y, et al. The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection. Ann Gastroenterol Surg. 2022;6(1):83–91.CrossRefPubMed
Metadata
Title
Value of preoperative evaluation of FEV1 in patients with destroyed lung undergoing pneumonectomy - a 20-year real-world study
Authors
Wenbo Li
Jing Zhao
Changfan Gong
Ran Zhou
Dongjie Yan
Hongyun Ruan
Fangchao Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02858-5

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.